Herpes Simplex Virus Infections Market

Herpes Simplex Virus Infections Market contains market size and forecasts of Herpes Simplex Virus Infections in Global, including the following market information:

• Global Herpes Simplex Virus Infections Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Herpes Simplex Virus Infections market was valued at 4673.6 million in 2021 and is projected to reach US$ 5529.3 million by 2028, at a CAGR of 2.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

General Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Herpes Simplex Virus Infections include Admedus Limited, Agenus Inc., Aicuris Anti-infective Cures Gmbh, Asahi Kasei Corporation, Chimerix Inc., Clinigen Group Plc, Daewoong Pharmaceutical Co., Ltd., F. Hoffmann-la Roche Ltd. and Glaxosmithkline Plc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Herpes Simplex Virus Infections companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Herpes Simplex Virus Infections Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Herpes Simplex Virus Infections Market Segment Percentages, by Type, 2021 (%)

• General Treatment
• Antiviral Therapy

Global Herpes Simplex Virus Infections Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Herpes Simplex Virus Infections Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Other

Global Herpes Simplex Virus Infections Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Herpes Simplex Virus Infections Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Herpes Simplex Virus Infections revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Herpes Simplex Virus Infections revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Admedus Limited
• Agenus Inc.
• Aicuris Anti-infective Cures Gmbh
• Asahi Kasei Corporation
• Chimerix Inc.
• Clinigen Group Plc
• Daewoong Pharmaceutical Co., Ltd.
• F. Hoffmann-la Roche Ltd.
• Glaxosmithkline Plc
• Maruho Co. Ltd.
• Merck
• Mylan
• Novartis
• Sanofi Pasteur
• Teva Pharmaceutical Industries Ltd.